Current role
Biotechnology · Healthcare
Board Member
2018-01-01–present
Bernadette Connaughton
Board Member
Halozyme Therapeutics, Inc. (HALO)Equibles does not estimate personal net worth.
Get an email with a short summary when Halozyme Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get HALO alertsAbout Bernadette Connaughton
Bernadette Connaughton is recorded as Board Member at Halozyme Therapeutics, Inc. (HALO) since January 1, 2018. The newest filing on record that lists Bernadette Connaughton as Board Member at Halozyme Therapeutics, Inc. (HALO) is dated March 26, 2021. Halozyme Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Halozyme Therapeutics, Inc. includes Helen Torley (CEO and Board Member), Darren Snellgrove (CFO), Elaine D. Sun (CFO) and 7 others.
Affiliation history
-
Current
2018-01-01–present
Last confirmed March 26, 2021
Company network
Leadership on record at Halozyme Therapeutics, Inc.
- Helen Torley CEO, Board Member
- Darren Snellgrove CFO
- Elaine D. Sun CFO
- Nicole LaBrosse CFO
- Cortney Caudill COO
- Mark Snyder General Counsel
- Barbara Duncan Board Member
- Connie L. Matsui Board Member
- Dannielle Appelhans Board Member
- James Daly Board Member
Recent activity
No call appearances or filed executive changes recorded yet.